Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents

Author： Holash Jocelyn Thurston Gavin Rudge John Yancopoulos George Adjei Alex Bergers Gabriele Pytowski Bronislaw Pegram Mark Gordon Michael

Publisher： Springer Publishing Company

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.25, Iss.2, 2006-06, pp. : 243-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endogenous Angiogenesis Inhibitors as Therapeutic Agents: Historical Perspective and Future Direction

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 223-236

Bentham Science Publishers

Access to resources Recommend Favorite

Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets

By Mao Hua LeBrun Drake G. Yang Jingxuan Zhu Vivian F. Li Min

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 48-56

Informa Healthcare

Access to resources Recommend Favorite

Magnolol Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-Dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways

By Kim Ki Mo Kim No Soo Kim Jinhee Park Jong-Shik Yi Jin Mu Lee Jun Bang Ok-Sun

Nutrition and Cancer, Vol. 65, Iss. 8, 2013-11 ,pp. : 1245-1253

Routledge Ltd

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways

By Wee Ping Wang Zhixiang

Cancers, Vol. 9, Iss. 5, 2017-05 ,pp. : 52-52

MDPI

Access to resources Recommend Favorite

Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-06 ,pp. : 427-433

Bentham Science Publishers

Access to resources Recommend Favorite